Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Pienta

Showing results (341-350 of 519) with videos related to

Pageof 52
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 2021
Detection of Early Progression with <sup>18</sup>F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen TherapyMark C Markowski, Pedro Isaacsson Velho, Mario A Eisenberger, et al.
Neoplasia (New York, N.Y.)|December 2, 2011
Detection of somatic copy number alterations in cancer using targeted exome capture sequencingRobert J Lonigro, Catherine S Grasso, Dan R Robinson, et al.
Urology Case Reports|March 16, 2018
Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [<sup>18</sup>F]DCFPyL PET/CT: Value of the PSMA-RADS-3D DesignationEugene Shenderov, Michael A Gorin, Seohyun Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Living with prostate cancer: patients' and spouses' psychosocial status and quality of lifeLaurel L Northouse, Darlene W Mood, James E Montie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 6, 2007
Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancerRohit Mehra, Scott A Tomlins, Ronglai Shen, et al.
The Prostate|November 4, 2021
Prostate cancer research in the 21st century; report from the 2021 Coffey-Holden prostate cancer academy meetingAndrea K Miyahira, Jelani C Zarif, Catherine C Coombs, et al.
Cancers|February 15, 2022
Characterization of Cellular and Acellular Analytes from Pre-Cystectomy Liquid Biopsies in Patients Newly Diagnosed with Primary Bladder CancerStephanie N Shishido, Salmaan Sayeed, George Courcoubetis, et al.
Journal of Cellular Biochemistry|March 5, 2009
Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer modelStefan Rozel, Craig J Galbán, Klaas Nicolay, et al.
The Prostate|December 12, 2019
Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy MeetingAndrea K Miyahira, Adam Sharp, Leigh Ellis, et al.
Clinical Genitourinary Cancer|May 30, 2006
Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: scientific rationale and study designKathleen W Beekman, A Dimitrios Colevas, Kathleen Cooney, et al.
Pageof 52

Showing results (341-350 of 519) with videos related to

Sort By:
Pageof 52
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 2021
Detection of Early Progression with <sup>18</sup>F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen TherapyMark C Markowski, Pedro Isaacsson Velho, Mario A Eisenberger, et al.
Neoplasia (New York, N.Y.)|December 2, 2011
Detection of somatic copy number alterations in cancer using targeted exome capture sequencingRobert J Lonigro, Catherine S Grasso, Dan R Robinson, et al.
Urology Case Reports|March 16, 2018
Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [<sup>18</sup>F]DCFPyL PET/CT: Value of the PSMA-RADS-3D DesignationEugene Shenderov, Michael A Gorin, Seohyun Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Living with prostate cancer: patients' and spouses' psychosocial status and quality of lifeLaurel L Northouse, Darlene W Mood, James E Montie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 6, 2007
Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancerRohit Mehra, Scott A Tomlins, Ronglai Shen, et al.
The Prostate|November 4, 2021
Prostate cancer research in the 21st century; report from the 2021 Coffey-Holden prostate cancer academy meetingAndrea K Miyahira, Jelani C Zarif, Catherine C Coombs, et al.
Cancers|February 15, 2022
Characterization of Cellular and Acellular Analytes from Pre-Cystectomy Liquid Biopsies in Patients Newly Diagnosed with Primary Bladder CancerStephanie N Shishido, Salmaan Sayeed, George Courcoubetis, et al.
Journal of Cellular Biochemistry|March 5, 2009
Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer modelStefan Rozel, Craig J Galbán, Klaas Nicolay, et al.
The Prostate|December 12, 2019
Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy MeetingAndrea K Miyahira, Adam Sharp, Leigh Ellis, et al.
Clinical Genitourinary Cancer|May 30, 2006
Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: scientific rationale and study designKathleen W Beekman, A Dimitrios Colevas, Kathleen Cooney, et al.
Pageof 52